News Updates
More Articles
- Advancing the Implementation of ICH E17: Collaborative Efforts Driving Simultaneous Global Drug Development in China
- How to Build Partnerships for Sustainable Healthcare
- eCTD v4.0: A Look at 2025 and Beyond
- Accelerated Approval as the New “Norm” in Gene Therapy for Rare Diseases
- Data Distortions: When Statistics Can Lead Us Astray in Drug Safety
Perspective: Changes in Site Ownership Will Positively Impact Clinical Trial Operations
Changes in Site Ownership Will Positively Impact Clinical Trial Operations
Perspective: Multisite clinical research corporations, often established through PE-backed M&A activity, offer the infrastructure, scale, and resources needed to address common operational bottlenecks.
×
